Catalyst Wire Dossier Catalyst Wire Dossier

BST-DERMON

· BioSyntech Canada Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BST-DERMON, covering 2009-02-05 to 2009-02-05. Get the full timeline:

Most recent: Clinical Trial Update: BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers [Phase 3]

See pricing